Wave Life Sciences (WVE) Receivables - Other (2018 - 2019)

Wave Life Sciences (WVE) posted Receivables - Other of $20.0 million for Q4 2019, little changed on a QoQ basis from $20.0 million in Q3 2019, and up 100.0% year-over-year from $10.0 million in Q4 2018.

Wave Life Sciences (WVE) Receivables - Other (2018 - 2019) Analysis & Trends

Wave Life Sciences' Receivables - Other history runs 2 years deep, the most recent figure standing at $20.0 million for Q4 2019.

  • Quarterly Receivables - Other rose 100.0% year-over-year to $20.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $20.0 million (up 100.0% YoY) and the FY2019 annual result came in at $20.0 million, up 100.0% from the prior year.
  • Receivables - Other was $20.0 million for Q4 2019 at Wave Life Sciences, roughly flat from $20.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $20.0 million in Q2 2019 and bottomed at $10.0 million in Q2 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Wave Life Sciences 1.16 Bn 612.38 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 20.00 Mn
Dec 31, 2019 20.00 Mn
Sep 30, 2019 20.00 Mn
Sep 30, 2019 20.00 Mn
Jun 30, 2019 20.00 Mn
Jun 30, 2019 20.00 Mn
Mar 31, 2019 10.00 Mn
Mar 31, 2019 10.00 Mn
Dec 31, 2018 10.00 Mn
Dec 31, 2018 10.00 Mn
Sep 30, 2018 10.00 Mn
Sep 30, 2018 10.00 Mn
Jun 30, 2018 10.00 Mn
Jun 30, 2018 10.00 Mn